Eledon Pharmaceuticals, Inc. (ELDN) stock
ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.98+0.01 (+0.51%)
Close on Nov 17, 2026Market cap $160.90MP/E –Yield –
Eledon Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Eledon Pharmaceuticals's pe ratio was 17.7× on Oct 31, 2025.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Oct 31, 2025 | 17.7× | – |
See a number that looks wrong?